Results 111 to 120 of about 91,055 (253)
Abstract Aims To individually evaluate the cardiovascular safety of low‐ and high‐affinity cardiac mitochondrial ATP‐sensitive potassium (mitoKATP) channel sulfonylureas by comparing each to dipeptidyl peptidase‐4 inhibitors (DPP‐4i), a generally cardiovascular‐neutral comparator, given prior evidence suggesting greater cardiovascular risk with high ...
Mei‐Hsiu Chen+8 more
wiley +1 more source
Intensive versus standard dose statin therapy: the costs and benefits for patients with acute coronary syndrome [PDF]
Introduction: Recent NICE guidance in England and Wales states that statin therapy for secondary CVD should "usually be initiated with a drug with a low acquisition cost (taking into account required daily dose and product price per dose)".
Ara, R.+3 more
core +3 more sources
Hyperhomocysteinemia and acute phase proteins in various forms of ischemic heart disease
Aim. To determine clinical significance of high concentrations of homocystein, C-reactive protein, fibrinogen in various forms of ischemic heart disease. Material and methods.
A D Paramonov+6 more
doaj
In a population of patients with stable CAD, circulating levels of PCSK9 are independently associated with the progression of adverse coronary plaque phenotypes, as assessed by serial coronary computed tomography angiography. At RNA‐seq analysis of whole blood, PCSK9 was linked to the expression of genes involved in the innate‐immune response.
Rosetta Ragusa+7 more
wiley +1 more source
Platelets of unstable angina patients as effector cells in terahertz radiation at NO frequency
Aim. To investigate the effects of electromagnetic terahertz waves at NO MSIP (molecular specter of radiation and absorption), 240 Hz, on platelet functional activity Р in natural electromagnetic field, as well as in crossed magnetic and electric fields ...
V. F. Kirichuk+5 more
doaj
Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard+14 more
wiley +1 more source
Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance
ABSTRACT Introduction The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients.
Manouk Dam+6 more
wiley +1 more source
WISDOM: history and early demise - was it inevitable?
In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core +1 more source
Abstract Background Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Sining Xie+4 more
wiley +1 more source
One thousand and two patients with cardiovascular disease (CVD) were observed over 10 years. Data were collected from 792 study participants. Severe periodontitis proved to be an independent risk factor for new cardiovascular events. Tooth brushing more than once a day and performing interdental hygiene were associated with decreased risk.
Stefan Reichert+3 more
wiley +1 more source